Illumina, Inc. (ILMN)

141.07 -4.76 (-3.26%) USD  |  NASDAQ  |  Jan 09, 16:00
141.75 +0.68 (+0.48%) After-Hours: 20:00
More

Illumina Research and Development Expense (Quarterly): 228.00M for Sept. 30, 2025

Research and Development Expense (Quarterly) Chart

View Research and Development Expense (Quarterly) for ILMN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Quarterly) Range, Past 5 Years

View Research and Development Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Quarterly) Benchmarks

View Research and Development Expense (Quarterly) Benchmarks
Start Trial
EXACT Sciences Corp. 117.22M
Guardant Health, Inc. 89.96M
GeneDx Holdings Corp. 19.59M
Waters Corp. 53.64M
Natera, Inc. 173.41M